Five Years of CRE RESPOND Forum
CRE RESPOND is proud to present the Five Years of CRE RESPOND Forum, our final event of 2026. The forum will take place on Friday 13 November 2026, from 12:30 pm - 6:00 pm.
The Five Years of CRE RESPOND Forum celebrates the collective achievements of our team, reflecting on the seminars, studies and research that have shaped our journey over the past five years. This event proudly highlights the impact of our work, in collaboration with hospitals and research centres around the world, in advancing antimicrobial stewardship and improving patient outcomes globally.
12:30pm - Light lunch and registrations
Auditorium, Frazer Institute, Herston
1:00pm - Session 1: Translating Research into Practice
- Welcome and introduction from the Chair: CRE RESPOND mission, friends and achievements
- Professor Jason Roberts, Director, CRE RESPOND, UQ Frazer Institute, Brisbane
- Becoming SMARRT-er, better antibiotic dosing in renal replacement therapy
- Dr Marta Ulldemolins, Infectious Diseases consultant, Hospital Clínic de Barcelona, Barcelona, Spain
- Improving antimicrobial therapy in Indigenous Australians
- Dr Danny Tsai, Director of Clinical Research (Acting) & Senior Research Fellow, Alice Springs Hospital & Flinders University, Alice Springs
- Implementing PK/PD-guided antimicrobial dosing in clinical practice
- Professor Monica Slavin, Director, Infectious Diseases Department, Peter McCallum Cancer Centre, Melbourne
- The importance of partner design in projects and health services
- Dr Natasha Roberts, Specialist Nurse, and Clinical Research Fellow, Metro North, Brisbane
2:45pm - Break
3:05pm - Session 2: Preclinical Studies and Clinical Pharmacokinetics
- Welcome from the Chair
- Dr Fekade Sime, NHMRC Emerging Leadership Fellow, University of Queensland, Brisbane
- The future of subcutaneous antibiotic dosing: Where are we now and where do we go from here?
- Dr Edward Raby, Clinical Microbiologist & Infectious Diseases Physician, Fiona Stanley Hospital, Perth
- Applying in vitro infection models to understand clinical problems
- Professor Cornelia Landersdorfer, Professor of Pharmaceutical Sciences, Monash University, Melbourne
- How is SAFE-ICU improving care for critically ill patients with severe fungal infections?
- Dr Patty Mitre, Postdoctoral Research Fellow, UQ Frazer Institute, Brisbane
- How has ASAP-ECMO changed our understanding of antibiotic dosing in ECMO?
- Dr Hafiz Abdul Aziz, NHMRC Emerging Leadership Fellow, University of Queensland, Brisbane
- BLING PK/PD Study - what we now know about the effect of beta-lactam concentration and patient outcomes
- Dr Marta Ulldemolins, Infectious Diseases Consultant, Hospital Clínic de Barcelona, Barcelona, Spain
- BLING-3 - there is a lot still to learn!
- Professor Jason Roberts, Director, CRE RESPOND, UQ Frazer Institute, Brisbane
4:35pm - Break
4:55pm - Session 3: Translating Dosing into Practice Change and Regulation
- Welcome from the Chair
- Emeritus Professor Jeffrey Lipman AM, University of Queensland, Brisbane
- Reducing surgical site infections in colorectal surgery
- Dr Rochelle Ryan, Consultant Anaesthetist, Sunshine Coast University Hospital, Sunshine Coast
- S. aureus bacteraemia - can we improve outcomes with even better dosing?
- Dr Paul Williams, Research Fellow, UQ Frazer Institute, Brisbane
- ROAD RCT - can we prevent AMR with better antimicrobial dosing?
- Dr Aaron Heffernan, Intensive Care/General Medicine Doctor, Gold Coast University Hospital, Gold Coast
- TDM vs Rapid diagnostics: Where can we make a DIRECT difference for severe infections?
- Dr Gene Chai, Lead Pharmacist, Alfred Health Intensive Care Unit, Melbourne
- Does BLING mean we should BUILD? Prolonged beta-lactam infusions in paediatric sepsis
- Professor Kristen Gibbons, Group Lead, Children’s Intensive Care Research Program, Child Health Research Centre, The University of Queensland, Brisbane
6:00pm - Close
If you have any questions about the forum please contact the CRE RESPOND team at cre.respond@uq.edu.au.
We gratefully acknowledge Pfizer's sponsorship of our 2026 education program.
